You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
柳藥股份(603368.SH)業績快報:2020年度淨利潤升4.42%至7.16億元
格隆匯 02-24 17:43

格隆匯 2 月 24日丨柳藥股份(603368.SH)發佈2020年度業績快報,實現營業總收入156.70億元,同比增長5.47%;歸屬於上市公司股東的淨利潤7.16億元,同比增長4.42%;歸屬於上市公司股東的扣除非經常性損益的淨利潤6.95億元,同比增長3.55%;基本每股收益1.97元。

2020年,公司實施2019年限制性股票激勵計劃、完成可轉換公司債券公開發行,2020年度限制性股票費用攤銷2330.26萬元、可轉換公司債券計提利息3430.9萬元,對本期歸屬於上市公司股東的淨利潤產生一定影響。2019年度限制性股票費用攤銷為1847.45萬元。

2020年公司經營業績繼續保持增長但增速有所放緩,主要原因是:在批發業務板塊,由於受疫情影響,醫院就診人數階段性減少導致醫院用藥量增速放緩,受此影響公司批發業務較去年同期增長1.21%,增速有一定下降。但在零售業務板塊,公司加快零售藥店佈局,發揮批零一體化優勢發展DTP藥店業務,積極促成處方外延、慢病管理等新零售服務落地,並大力拓展網上藥店業務,推動線上、線下業務的融合,從而繼續保持零售業務較快增長,2020年公司零售業務較去年同期增長31.72%。此外,在工業板塊,公司提升產品質量,豐富產品品種,發揮工商協同優勢推動工業產品銷售規模,從而實現在疫情衝擊下工業板塊營業收入仍然保持增長,較去年同期增長10.78%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account